Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study
To determine the prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study is a prospective population-based cohort study in 7983 participants aged > or =55. Heart failure was defined according to criteria of the European Society of Cardiology. Prevalence was h...
Gespeichert in:
| Veröffentlicht in: | European heart journal 2004-09, Vol.25 (18), p.1614-1619 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1619 |
|---|---|
| container_issue | 18 |
| container_start_page | 1614 |
| container_title | European heart journal |
| container_volume | 25 |
| creator | BLEUMINK, Gysèle S KNETSCH, Anneke M STURKENBOOM, Miriam C. J. M STRAITS, Sabine M. J. M HOFMAN, Albert DECKERS, Jaap W WITTEMAN, Jacqueline C. M STRICKER, Bruno H. Ch |
| description | To determine the prevalence, incidence rate, lifetime risk and prognosis of heart failure.
The Rotterdam Study is a prospective population-based cohort study in 7983 participants aged > or =55. Heart failure was defined according to criteria of the European Society of Cardiology. Prevalence was higher in men and increased with age from 0.9% in subjects aged 55-64 to 17.4% in those aged > or =85. Incidence rate of heart failure was 14.4/1000 person-years (95% CI 13.4-15.5) and was higher in men (17.6/1000 man-years, 95% CI 15.8-19.5) than in women (12.5/1000 woman-years, 95% CI 11.3-13.8). Incidence rate increased with age from 1.4/1000 person-years in those aged 55-59 to 47.4/1000 person-years in those aged > or =90. Lifetime risk was 33% for men and 29% for women at the age of 55. Survival after incident heart failure was 86% at 30 days, 63% at 1 year, 51% at 2 years and 35% at 5 years of follow-up.
Prevalence and incidence rates of heart failure are high. In individuals aged 55, almost 1 in 3 will develop heart failure during their remaining lifespan. Heart failure continues to be a fatal disease, with only 35% surviving 5 years after the first diagnosis. |
| doi_str_mv | 10.1016/j.ehj.2004.06.038 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66848938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66848938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-d247d4749991b3744eec1664d435f3cfea14a3bfcea2feee81197c87e1ef2ee33</originalsourceid><addsrcrecordid>eNpVkM1KAzEUhYMoWqsP4Eay0ZUzJpNMZsadFP-gIGoFd0Oa3LSp81OTjNAH8L0NWBFX957Lx7mHg9AJJSklVFyuUliu0owQnhKRElbuoBHNsyypBM930YjQKk-EKN8O0KH3K0JIKajYRwc0ZzmlgozQ19Mgu2DNxnYLHJaAlyBdwEbaZnCAYW01tFZd4bWDT9lAp-AC207Fc1yxkyHqxhoIto3S-ncsOx3pftH13nrcm_-WKZ7FL899COC0bPFLGPTmCO0Z2Xg43s4xer29mU3uk-nj3cPkepqomDckOuOF5gWvqorOWcE5gKJCcM1ZbpgyICmXbG4UyMwAQElpVaiyAAomA2BsjM5_fGO-jwF8qFvrFTSN7KAffB274mXFygiebsFh3oKu18620m3q3-IicLYFpFeyMU7GTvwfJ0iVU8bYN5KKgDE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66848938</pqid></control><display><type>article</type><title>Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>BLEUMINK, Gysèle S ; KNETSCH, Anneke M ; STURKENBOOM, Miriam C. J. M ; STRAITS, Sabine M. J. M ; HOFMAN, Albert ; DECKERS, Jaap W ; WITTEMAN, Jacqueline C. M ; STRICKER, Bruno H. Ch</creator><creatorcontrib>BLEUMINK, Gysèle S ; KNETSCH, Anneke M ; STURKENBOOM, Miriam C. J. M ; STRAITS, Sabine M. J. M ; HOFMAN, Albert ; DECKERS, Jaap W ; WITTEMAN, Jacqueline C. M ; STRICKER, Bruno H. Ch</creatorcontrib><description>To determine the prevalence, incidence rate, lifetime risk and prognosis of heart failure.
The Rotterdam Study is a prospective population-based cohort study in 7983 participants aged > or =55. Heart failure was defined according to criteria of the European Society of Cardiology. Prevalence was higher in men and increased with age from 0.9% in subjects aged 55-64 to 17.4% in those aged > or =85. Incidence rate of heart failure was 14.4/1000 person-years (95% CI 13.4-15.5) and was higher in men (17.6/1000 man-years, 95% CI 15.8-19.5) than in women (12.5/1000 woman-years, 95% CI 11.3-13.8). Incidence rate increased with age from 1.4/1000 person-years in those aged 55-59 to 47.4/1000 person-years in those aged > or =90. Lifetime risk was 33% for men and 29% for women at the age of 55. Survival after incident heart failure was 86% at 30 days, 63% at 1 year, 51% at 2 years and 35% at 5 years of follow-up.
Prevalence and incidence rates of heart failure are high. In individuals aged 55, almost 1 in 3 will develop heart failure during their remaining lifespan. Heart failure continues to be a fatal disease, with only 35% surviving 5 years after the first diagnosis.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1016/j.ehj.2004.06.038</identifier><identifier>PMID: 15351160</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Age Distribution ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cardiology. Vascular system ; Disease Outbreaks ; Epidemiologic Methods ; Female ; Heart ; Heart Failure - epidemiology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Male ; Medical sciences ; Middle Aged ; Netherlands - epidemiology</subject><ispartof>European heart journal, 2004-09, Vol.25 (18), p.1614-1619</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-d247d4749991b3744eec1664d435f3cfea14a3bfcea2feee81197c87e1ef2ee33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16095133$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15351160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BLEUMINK, Gysèle S</creatorcontrib><creatorcontrib>KNETSCH, Anneke M</creatorcontrib><creatorcontrib>STURKENBOOM, Miriam C. J. M</creatorcontrib><creatorcontrib>STRAITS, Sabine M. J. M</creatorcontrib><creatorcontrib>HOFMAN, Albert</creatorcontrib><creatorcontrib>DECKERS, Jaap W</creatorcontrib><creatorcontrib>WITTEMAN, Jacqueline C. M</creatorcontrib><creatorcontrib>STRICKER, Bruno H. Ch</creatorcontrib><title>Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>To determine the prevalence, incidence rate, lifetime risk and prognosis of heart failure.
The Rotterdam Study is a prospective population-based cohort study in 7983 participants aged > or =55. Heart failure was defined according to criteria of the European Society of Cardiology. Prevalence was higher in men and increased with age from 0.9% in subjects aged 55-64 to 17.4% in those aged > or =85. Incidence rate of heart failure was 14.4/1000 person-years (95% CI 13.4-15.5) and was higher in men (17.6/1000 man-years, 95% CI 15.8-19.5) than in women (12.5/1000 woman-years, 95% CI 11.3-13.8). Incidence rate increased with age from 1.4/1000 person-years in those aged 55-59 to 47.4/1000 person-years in those aged > or =90. Lifetime risk was 33% for men and 29% for women at the age of 55. Survival after incident heart failure was 86% at 30 days, 63% at 1 year, 51% at 2 years and 35% at 5 years of follow-up.
Prevalence and incidence rates of heart failure are high. In individuals aged 55, almost 1 in 3 will develop heart failure during their remaining lifespan. Heart failure continues to be a fatal disease, with only 35% surviving 5 years after the first diagnosis.</description><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Disease Outbreaks</subject><subject>Epidemiologic Methods</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Failure - epidemiology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Netherlands - epidemiology</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1KAzEUhYMoWqsP4Eay0ZUzJpNMZsadFP-gIGoFd0Oa3LSp81OTjNAH8L0NWBFX957Lx7mHg9AJJSklVFyuUliu0owQnhKRElbuoBHNsyypBM930YjQKk-EKN8O0KH3K0JIKajYRwc0ZzmlgozQ19Mgu2DNxnYLHJaAlyBdwEbaZnCAYW01tFZd4bWDT9lAp-AC207Fc1yxkyHqxhoIto3S-ncsOx3pftH13nrcm_-WKZ7FL899COC0bPFLGPTmCO0Z2Xg43s4xer29mU3uk-nj3cPkepqomDckOuOF5gWvqorOWcE5gKJCcM1ZbpgyICmXbG4UyMwAQElpVaiyAAomA2BsjM5_fGO-jwF8qFvrFTSN7KAffB274mXFygiebsFh3oKu18620m3q3-IicLYFpFeyMU7GTvwfJ0iVU8bYN5KKgDE</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>BLEUMINK, Gysèle S</creator><creator>KNETSCH, Anneke M</creator><creator>STURKENBOOM, Miriam C. J. M</creator><creator>STRAITS, Sabine M. J. M</creator><creator>HOFMAN, Albert</creator><creator>DECKERS, Jaap W</creator><creator>WITTEMAN, Jacqueline C. M</creator><creator>STRICKER, Bruno H. Ch</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study</title><author>BLEUMINK, Gysèle S ; KNETSCH, Anneke M ; STURKENBOOM, Miriam C. J. M ; STRAITS, Sabine M. J. M ; HOFMAN, Albert ; DECKERS, Jaap W ; WITTEMAN, Jacqueline C. M ; STRICKER, Bruno H. Ch</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-d247d4749991b3744eec1664d435f3cfea14a3bfcea2feee81197c87e1ef2ee33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Disease Outbreaks</topic><topic>Epidemiologic Methods</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Failure - epidemiology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Netherlands - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BLEUMINK, Gysèle S</creatorcontrib><creatorcontrib>KNETSCH, Anneke M</creatorcontrib><creatorcontrib>STURKENBOOM, Miriam C. J. M</creatorcontrib><creatorcontrib>STRAITS, Sabine M. J. M</creatorcontrib><creatorcontrib>HOFMAN, Albert</creatorcontrib><creatorcontrib>DECKERS, Jaap W</creatorcontrib><creatorcontrib>WITTEMAN, Jacqueline C. M</creatorcontrib><creatorcontrib>STRICKER, Bruno H. Ch</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BLEUMINK, Gysèle S</au><au>KNETSCH, Anneke M</au><au>STURKENBOOM, Miriam C. J. M</au><au>STRAITS, Sabine M. J. M</au><au>HOFMAN, Albert</au><au>DECKERS, Jaap W</au><au>WITTEMAN, Jacqueline C. M</au><au>STRICKER, Bruno H. Ch</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>25</volume><issue>18</issue><spage>1614</spage><epage>1619</epage><pages>1614-1619</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>To determine the prevalence, incidence rate, lifetime risk and prognosis of heart failure.
The Rotterdam Study is a prospective population-based cohort study in 7983 participants aged > or =55. Heart failure was defined according to criteria of the European Society of Cardiology. Prevalence was higher in men and increased with age from 0.9% in subjects aged 55-64 to 17.4% in those aged > or =85. Incidence rate of heart failure was 14.4/1000 person-years (95% CI 13.4-15.5) and was higher in men (17.6/1000 man-years, 95% CI 15.8-19.5) than in women (12.5/1000 woman-years, 95% CI 11.3-13.8). Incidence rate increased with age from 1.4/1000 person-years in those aged 55-59 to 47.4/1000 person-years in those aged > or =90. Lifetime risk was 33% for men and 29% for women at the age of 55. Survival after incident heart failure was 86% at 30 days, 63% at 1 year, 51% at 2 years and 35% at 5 years of follow-up.
Prevalence and incidence rates of heart failure are high. In individuals aged 55, almost 1 in 3 will develop heart failure during their remaining lifespan. Heart failure continues to be a fatal disease, with only 35% surviving 5 years after the first diagnosis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>15351160</pmid><doi>10.1016/j.ehj.2004.06.038</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-668X |
| ispartof | European heart journal, 2004-09, Vol.25 (18), p.1614-1619 |
| issn | 0195-668X 1522-9645 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66848938 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Age Distribution Aged Aged, 80 and over Biological and medical sciences Cardiology. Vascular system Disease Outbreaks Epidemiologic Methods Female Heart Heart Failure - epidemiology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Male Medical sciences Middle Aged Netherlands - epidemiology |
| title | Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A24%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantifying%20the%20heart%20failure%20epidemic:%20prevalence,%20incidence%20rate,%20lifetime%20risk%20and%20prognosis%20of%20heart%20failure.%20The%20Rotterdam%20Study&rft.jtitle=European%20heart%20journal&rft.au=BLEUMINK,%20Gys%C3%A8le%20S&rft.date=2004-09-01&rft.volume=25&rft.issue=18&rft.spage=1614&rft.epage=1619&rft.pages=1614-1619&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1016/j.ehj.2004.06.038&rft_dat=%3Cproquest_pubme%3E66848938%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66848938&rft_id=info:pmid/15351160&rfr_iscdi=true |